βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors

被引：0
|
作者：
Michal Chovanec
Zuzana Cierna
Viera Miskovska
Katarina Machalekova
Katarina Kalavska
Katarina Rejlekova
Daniela Svetlovska
Dusan Macak
Stanislav Spanik
Karol Kajo
Pavel Babal
Michal Mego
Jozef Mardiak
机构：
[1] Comenius University and National Cancer Institute,2nd Department of Oncology, Faculty of Medicine
[2] National Cancer Institute,Department of Pathology, Faculty of Medicine
[3] Comenius University,1st Department of Oncology, Faculty of Medicine
[4] Comenius University,Translational Research Unit, Faculty of Medicine
[5] St. Elisabeth Cancer Institute,undefined
[6] Comenius University,undefined
[7] Cancer Research Institute,undefined
[8] Slovak Academy of Sciences,undefined
[9] Faculty Hospital with Policlinics Skalica,undefined
[10] a.s,undefined
来源：
BMC Cancer | / 18卷
关键词：
βcatenin; WNTβ pathway; PD-L1; Systemic-immune inflammation; Tumor infiltrating lymphocytes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors
    Chovanec, Michal
    Cierna, Zuzana
    Miskovska, Viera
    Machalekova, Katarina
    Kalavska, Katarina
    Rejlekova, Katarina
    Svetlovska, Daniela
    Macak, Dusan
    Spanik, Stanislav
    Kajo, Karol
    Babal, Pavel
    Mego, Michal
    Mardiak, Jozef
    BMC CANCER, 2018, 18
  • [2] Immune cell infiltration of testicular germ cell tumors - a clinical approach
    Dittmar, F.
    Heyer, J.
    Figura, M.
    Islam, R.
    Hartmann, K.
    Kliesch, S.
    Wagenlehner, F.
    Hedger, M.
    Loveland, B.
    Loveland, K.
    Fietz, D.
    Schuppe, H-C
    EUROPEAN UROLOGY, 2022, 81 : S835 - S835
  • [3] Clinical epidemiology of testicular germ cell tumors
    Dieckmann, KP
    Pichlmeier, U
    WORLD JOURNAL OF UROLOGY, 2004, 22 (01) : 2 - 14
  • [4] Clinical epidemiology of testicular germ cell tumors
    K.-P. Dieckmann
    U. Pichlmeier
    World Journal of Urology, 2004, 22 : 2 - 14
  • [5] Management of poor-prognosis testicular germ cell tumors
    Khurana, Kiranpreet
    Gilligan, Timothy D.
    Stephenson, Andrew J.
    INDIAN JOURNAL OF UROLOGY, 2010, 26 (01) : 108 - 114
  • [6] Glypican 3: A novel marker in testicular germ cell tumors
    Zynger, Debra L.
    Dimov, Nikolay D.
    Luan, Chunyan
    Teh, Bin Tean
    Yang, Ximing J.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (12) : 1570 - 1575
  • [7] Glypican 3: A novel marker in testicular germ cell tumors
    Zynger, DL
    Dimov, ND
    Luan, C
    Yang, XJ
    LABORATORY INVESTIGATION, 2006, 86 : 171A - 171A
  • [8] Glypican 3: A novel marker in testicular germ cell tumors
    Zynger, DL
    Dimov, ND
    Luan, C
    Yang, XJ
    MODERN PATHOLOGY, 2006, 19 : 171A - 171A
  • [9] Upregulated HAVCR2: A Prognostic and Immune-Related Marker in Testicular Germ Cell Tumors
    Xue, Lei
    Zhao, Xueheng
    Jia, Hanbo
    Xie, Yu
    Wen, Yuheng
    Liang, Yu
    Liu, Zhizhong
    Cao, Jian
    Bo, Hao
    Liu, Lvjun
    Guo, Jie
    ANDROLOGIA, 2023, 2023
  • [10] Testicular germ cell tumors: biology and clinical update
    Mannuel, Heather D.
    Mitikiri, Nirupama
    Khan, Maleha
    Hussain, Arif
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) : 266 - 271
12345